Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,477 | -32,845 | -14,539 | -41,092 | -27,069 |
| Depreciation Amortization | 223 | 145 | 71 | -1,377 | 258 |
| Accounts receivable | 10 | -160 | -307 | -10 | -1,727 |
| Other Working Capital | 3,750 | 1,274 | -1,895 | 9,247 | 9,762 |
| Other Operating Activity | 3,211 | 2,386 | 1,542 | 4,700 | 5,441 |
| Operating Cash Flow | $-43,283 | $-29,200 | $-15,128 | $-28,532 | $-13,335 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -186 | -132 | -36 | -35 | -35 |
| Investing Cash Flow | $-186 | $-132 | $-36 | $-35 | $-35 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,852 | -741 | N/A | N/A | N/A |
| Common Stock Issued | 9,535 | 33,890 | 24 | 14,304 | 12,632 |
| Other Financing Activity | 29,186 | 0 | 29,186 | -31 | 0 |
| Financing Cash Flow | $36,869 | $33,149 | $29,210 | $14,273 | $12,632 |
| Beginning Cash Position | 60,268 | 60,268 | 60,268 | 74,562 | 74,562 |
| End Cash Position | 53,668 | 64,085 | 74,314 | 60,268 | 73,824 |
| Net Cash Flow | $-6,600 | $3,817 | $14,046 | $-14,294 | $-738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,283 | -29,200 | -15,128 | -28,532 | -13,335 |
| Capital Expenditure | -186 | -132 | -36 | -35 | -35 |
| Free Cash Flow | -43,469 | -29,332 | -15,164 | -28,567 | -13,370 |